Clinical and therapeutic impact of 18F-FDG PET/CT whole-body acquisition including lower limbs in patients with malignant melanoma

Nuclear Medicine Communications

Volumn 31, Issue 9, 2010, Pages 766-772

  Querelloua, Solene ^a,c   Keromnesa, Nathalie ^a   Abgrala, Ronan ^a   Sassolasb, Bruno ^b   Rouxa, Pierre Yves Le ^a   Cavareca, Marie Béatrice ^a   Duc Penneca, Alexandra Le ^a   Couturierc, Olivier ^c   Salauna, Pierre Yves ^a  

^a Departments of Nuclear Medicine   (United States)

^b ANGERS UNIVERSITY HOSPITAL   (France)

^c BREST UNIVERSITY HOSPITAL   (France)

Author keywords

FDG PET CT; Lower limbs; Melanoma; Metastases; Oncology

Indexed keywords

FLUORODEOXYGLUCOSE F 18;

ADRENAL GLAND; ADULT; AGED; ARTICLE; CANCER STAGING; CLINICAL DECISION MAKING; COMPUTER ASSISTED EMISSION TOMOGRAPHY; CONTROLLED STUDY; CORRELATION ANALYSIS; DRUG UPTAKE; FEMALE; FOLLOW UP; HUMAN; LEG; LIVER; LUNG; LYMPH NODE; MAJOR CLINICAL STUDY; MALE; MELANOMA; PRIMARY TUMOR; RADIODIAGNOSIS; RETROSPECTIVE STUDY; WHOLE BODY RADIATION;

ADULT; AGED; AGED, 80 AND OVER; FEMALE; FLUORODEOXYGLUCOSE F18; HUMANS; LOWER EXTREMITY; MALE; MELANOMA; MIDDLE AGED; NEOPLASM STAGING; POSITRON-EMISSION TOMOGRAPHY; RETROSPECTIVE STUDIES; TOMOGRAPHY, X-RAY COMPUTED; WHOLE BODY IMAGING;

EID: 77956870166     PISSN: 01433636     EISSN: None     Source Type: Journal    
DOI: 10.1097/MNM.0b013e32833cb8b7     Document Type: Article

References (15)

1. 18F)-fluoro-D-glucose whole body positron emission tomography for managing patients with melanoma, the referring physician's perspective. Mol Imaging Biol 2002; 4:185-190.
2. 18F]fluorodeoxyglucose positron emission tomography on surgical management of melanoma patients. British J Surg 2006; 93:243-249.
3. Belhocine TZ, Scott AM, Even-Sapir E, Urbain JL, Essner R. Role of nuclear medicine in the management of cutaneous malignant melanoma. J Nucl Med 2006; 47:957-967.
4. 18F-FDG PET/CT imaging for N- and M-staging of malignant melanoma: experience with 250 consecutive patients. J Clin Oncol 2006; 24:1178-1187.
5. Harris MT, Berlangieri SU, Cebon JS, Davis ID, Scott AM. Impact of 2-deoxy- 2[F-18]fluoro-D-glucose positron emission tomography on the management of patients with advanced melanoma. Mol Imaging Biol 2005; 7:304-308.
6. Coleman RE, Delbeke D, Guiberteau MJ, Conti PS, Royal HD,Weinreb JC, et al. Concurrent PET/CT with an integrated imaging system: intersociety dialogue from the Joint Working Group of the American College of Radiology, the Society of Nuclear Medicine, and the Society of Computed Body Tomography and Magnetic Resonance. J Nucl Med 2005; 46:1225-1239. (Pubitemid 43741086)
7. Stam-Posthuma JJ, Van Duinen C, Scheffer E, Vink J, Bergman W. Multiple primary melanomas. J Am Acad Dermatol 2001; 44:22-27.
8. Titus-Ernstoff L, Perry AE, Spencer SK, Gibson J, Ding J, Cole B, et al. Multiple primary melanoma: two-year results from a population-based study. Arch Dermatol 2006; 142:433-438.
9. Tromme I, Richez P. Epidé miologie, facteurs de risque et dé pistage du mé lanome. Louvain Médical 2007; 126:190-200.
10. Battistella M, Trabelsi S, Terrier-Lacombe MJ, Leboulleux S, Robert C. Histiocytofibrome hyperfixant à la tomographie par é mission de positons: un faux positif trompeur dans le suivi d'un mé lanome avec mé tastases sous-cutané es. MMB, Dir Com IGR. 12-2007. [French]
11. Mijnhout GS, Hoekstra OS, Van Tulder MW, Teule GJ, Devillé WL. Systematic review of the diagnostic accuracy of (18)F-fluorodeoxyglucose positron emission tomography in melanoma patients. Cancer 2001; 91:1530-1542.
12. Schwimmer J, Essner R, Patel A, Jahan SA, Shepherd JE, Park K, et al. A review of the literature for whole-body FDG PET in the management of patients with melanoma. Q J Nucl Med 2000; 44:153-167. (Pubitemid 30623521)
13. Lö ffler M, Weckesser M, Franzius C, Nashan D, Schober O. Malignant melanoma and (18)F-FDG-PET: should the whole body scan include the legs? Nuklearmedizin 2003; 42:167-172.
14. 18F-FDG PET-CT imaging for patients with malignant melanoma. Nucl Med Commun 2007; 28:688-695.
15. Leiter U, Meier F, Schittek B, Garbe C. The natural course of cutaneous melanoma. J Surg Oncol 2004; 86:172-178.